We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Innovative Von Willebrand Factor Test Launched in US

By LabMedica International staff writers
Posted on 18 Apr 2017
Print article
Image: A ribbon model of von Willebrand factor, mutations of which can cause the inherited blood disorder von Willebrand Disease (Photo courtesy of Wikimedia).
Image: A ribbon model of von Willebrand factor, mutations of which can cause the inherited blood disorder von Willebrand Disease (Photo courtesy of Wikimedia).
A center for blood diseases has launched a new test in the United States to more accurately measure activity of von Willebrand Factor (VWF), one of the blood-clotting proteins, for people with the inherited bleeding disorder von Willebrand disease (VWD).

The new assay – “VWF GPIbM Activity” – was launched by BloodCenter of Wisconsin (Milwaukee, WI, USA), part of Versiti. The test employs patented technology previously not used in the USA that provides more precise measurement of VWF platelet-binding activity – critical for making an accurate diagnosis of VWD. BloodCenter of Wisconsin is the first organization to make this test available in the US in a clinical laboratory setting.

Though there is no cure for VWD, treatment can help prevent or stop bleeding episodes. Making the most accurate diagnosis is critical to identifying the most appropriate treatment to manage the disease.

VWF GPIbM Activity detects qualitative VWF defects, reducing variability and providing more precise, reliable, and sensitive test results. Clinical hematologists can thus be more confident that the results reflect their patient’s clinical scenario.

“As a physician caring for individuals with inherited bleeding disorders, this development is an exciting advancement in von Willebrand disease diagnostics,” said Johnathan Roberts, MD, of the Bleeding & Clotting Disorders Institute (Peoria, IL, USA), “This assay will reduce some of the diagnostic challenges in caring for individuals with VWD.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.